转移性乳腺癌:病例报告

IF 0.1 Q4 OBSTETRICS & GYNECOLOGY
N. Camejo , F. Nantes , C. Castillo , D. Centurion , G. Krygier
{"title":"转移性乳腺癌:病例报告","authors":"N. Camejo ,&nbsp;F. Nantes ,&nbsp;C. Castillo ,&nbsp;D. Centurion ,&nbsp;G. Krygier","doi":"10.1016/j.gine.2023.100926","DOIUrl":null,"url":null,"abstract":"<div><h3>Introduction</h3><p>Metaplastic breast carcinoma (MBC) is a rare and aggressive type of breast cancer that is often diagnosed in advanced stages, with large tumors and a high histological grade. In this study, we present a case of MBC, and conduct a review and discussion of the related literature.</p></div><div><h3>Main symptoms or clinical findings</h3><p>A 35-year-old patient with no relevant personal or family history presents with a progressively growing 2 cm breast mass, which, over time, develops into nipple retraction and breast pain. A breast ultrasound reveals a suspicious-looking polilobulated solid mass. In summary: a BI-RADS 5 mass in the left breast.</p></div><div><h3>Main diagnoses, therapeutic interventions, and outcomes</h3><p>A core biopsy is performed, and the pathology report reveals an infiltrating ductal carcinoma, metaplastic variety, triple-negative with PDL1 expression &gt; 1%. A modified radical mastectomy is performed. During follow-up, pulmonary metastasis is diagnosed, and the patient receives first and second-line systemic treatment.</p></div><div><h3>Conclusions</h3><p>Given the aggressive nature of this type of tumor and the limited treatment options available, participation in clinical trials may be considered to improve outcomes in these patients. A multidisciplinary approach, and review in a tumor committee are essential to guide therapeutic decisions and provide the best possible care for these patients.</p><p>.</p></div>","PeriodicalId":41294,"journal":{"name":"Clinica e Investigacion en Ginecologia y Obstetricia","volume":"51 1","pages":"Article 100926"},"PeriodicalIF":0.1000,"publicationDate":"2023-12-07","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Cáncer de mama metaplásico: a propósito de un caso\",\"authors\":\"N. Camejo ,&nbsp;F. Nantes ,&nbsp;C. Castillo ,&nbsp;D. Centurion ,&nbsp;G. Krygier\",\"doi\":\"10.1016/j.gine.2023.100926\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Introduction</h3><p>Metaplastic breast carcinoma (MBC) is a rare and aggressive type of breast cancer that is often diagnosed in advanced stages, with large tumors and a high histological grade. In this study, we present a case of MBC, and conduct a review and discussion of the related literature.</p></div><div><h3>Main symptoms or clinical findings</h3><p>A 35-year-old patient with no relevant personal or family history presents with a progressively growing 2 cm breast mass, which, over time, develops into nipple retraction and breast pain. A breast ultrasound reveals a suspicious-looking polilobulated solid mass. In summary: a BI-RADS 5 mass in the left breast.</p></div><div><h3>Main diagnoses, therapeutic interventions, and outcomes</h3><p>A core biopsy is performed, and the pathology report reveals an infiltrating ductal carcinoma, metaplastic variety, triple-negative with PDL1 expression &gt; 1%. A modified radical mastectomy is performed. During follow-up, pulmonary metastasis is diagnosed, and the patient receives first and second-line systemic treatment.</p></div><div><h3>Conclusions</h3><p>Given the aggressive nature of this type of tumor and the limited treatment options available, participation in clinical trials may be considered to improve outcomes in these patients. A multidisciplinary approach, and review in a tumor committee are essential to guide therapeutic decisions and provide the best possible care for these patients.</p><p>.</p></div>\",\"PeriodicalId\":41294,\"journal\":{\"name\":\"Clinica e Investigacion en Ginecologia y Obstetricia\",\"volume\":\"51 1\",\"pages\":\"Article 100926\"},\"PeriodicalIF\":0.1000,\"publicationDate\":\"2023-12-07\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinica e Investigacion en Ginecologia y Obstetricia\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0210573X23000965\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinica e Investigacion en Ginecologia y Obstetricia","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0210573X23000965","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

导言间变性乳腺癌(MBC)是一种罕见的侵袭性乳腺癌,通常诊断为晚期,肿瘤大且组织学分级高。主要症状或临床发现一名 35 岁的患者,无相关个人或家族史,因逐渐增大的 2 厘米乳房肿块就诊,随着时间的推移,肿块发展为乳头回缩和乳房疼痛。乳腺超声检查发现了一个外观可疑的多叶实性肿块。进行了核心活检,病理报告显示为浸润性导管癌,变性类型,三阴性,PDL1表达> 1%。患者接受了改良根治性乳房切除术。在随访期间,患者被诊断出肺部转移,并接受了一线和二线系统治疗。多学科方法和肿瘤委员会的审查对于指导治疗决策和为这些患者提供最佳治疗至关重要。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
Cáncer de mama metaplásico: a propósito de un caso

Introduction

Metaplastic breast carcinoma (MBC) is a rare and aggressive type of breast cancer that is often diagnosed in advanced stages, with large tumors and a high histological grade. In this study, we present a case of MBC, and conduct a review and discussion of the related literature.

Main symptoms or clinical findings

A 35-year-old patient with no relevant personal or family history presents with a progressively growing 2 cm breast mass, which, over time, develops into nipple retraction and breast pain. A breast ultrasound reveals a suspicious-looking polilobulated solid mass. In summary: a BI-RADS 5 mass in the left breast.

Main diagnoses, therapeutic interventions, and outcomes

A core biopsy is performed, and the pathology report reveals an infiltrating ductal carcinoma, metaplastic variety, triple-negative with PDL1 expression > 1%. A modified radical mastectomy is performed. During follow-up, pulmonary metastasis is diagnosed, and the patient receives first and second-line systemic treatment.

Conclusions

Given the aggressive nature of this type of tumor and the limited treatment options available, participation in clinical trials may be considered to improve outcomes in these patients. A multidisciplinary approach, and review in a tumor committee are essential to guide therapeutic decisions and provide the best possible care for these patients.

.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
0.20
自引率
0.00%
发文量
54
期刊介绍: Una excelente publicación para mantenerse al día en los temas de máximo interés de la ginecología de vanguardia. Resulta idónea tanto para el especialista en ginecología, como en obstetricia o en pediatría, y está presente en los más prestigiosos índices de referencia en medicina.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信